No Data
No Data
Wanbangde Pharmaceutical's Subsidiary Gains Approval for Cefaclor Granules
Wanbangde Pharmaceutical Holding Group Co., Ltd.'s (SZSE:002082) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Wanbangde Pharmaceutical's HIE Drug Gets FDA Nod for Clinical Trial
Wanbangde Pharmaceutical Holding Group's (SZSE:002082) Earnings Have Declined Over Three Years, Contributing to Shareholders 35% Loss
Wepon Pharmaceutical Unit's Chlorpromazine Hydrochloride Tablets Passes Regulatory Evaluation
Subdued Growth No Barrier To Wanbangde Pharmaceutical Holding Group Co., Ltd. (SZSE:002082) With Shares Advancing 38%
No Data